NCT01859481

Brief Summary

Evaluation of headache response at 2 hours for active treated attacks for increasing dose.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
971

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Mar 2000

Geographic Reach
14 countries

140 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2000

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2002

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2002

Completed
11.2 years until next milestone

First Submitted

Initial submission to the registry

May 13, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 22, 2013

Completed
Last Updated

January 27, 2021

Status Verified

January 1, 2021

Enrollment Period

2 years

First QC Date

May 13, 2013

Last Update Submit

January 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Consistency of headache response (3 responses out of 3 active treated attacks) . Headache response was defined as migraine headache pain of moderate or severe intensity pre dose becoming basent or mild within 2 hours post dose.

    24 weeks

Secondary Outcomes (1)

  • Consistency of headache response (2 responses out of 3 active treated attacks). Headache response was defined as migraine headache pain of moderate or severe intensity pre dose becoming basent or mild within 2 hours post dose.

    24 weeks

Study Arms (3)

Placebo

PLACEBO COMPARATOR
Drug: Placebo

Eletriptan HBr 40 mg

EXPERIMENTAL
Drug: Eletriptan HBr 40 mg

Eletriptan HBr 80 mg

EXPERIMENTAL
Drug: Eletriptan HBr 80 mg

Interventions

All subjects will receive open label eletriptan 40 mg per attack for the first three attacks in the phase 1 of the study. For the next 4 attacks subjects will be assigned to either eletriptan 40 mg or 80 mg group based on the response in the phase 1 portion of the study. In phase II, in each group subjects will receive eletriptan 40 mg or 80 mg for 3 attacks and placebo for 1 attack. In each group double-blind placebo will be inserted at random.

Placebo

All subjects will receive open label eletriptan 40 mg per attack for the first three attacks in the phase 1 of the study. For the next 4 attacks subjects will be assigned to either eletriptan 40 mg or 80 mg group based on the response in the phase 1 portion of the study. In phase II, in each group subjects will receive eletriptan 40 mg or 80 mg for 3 attacks and placebo for 1 attack. In each group double-blind placebo will be inserted at random.

Eletriptan HBr 40 mg

All subjects will receive open label eletriptan 40 mg per attack for the first three attacks in the phase 1 of the study. For the next 4 attacks subjects will be assigned to either eletriptan 40 mg or 80 mg group based on the response in the phase 1 portion of the study. In phase II, in each group subjects will receive eletriptan 40 mg or 80 mg for 3 attacks and placebo for 1 attack. In each group double-blind placebo will be inserted at random.

Eletriptan HBr 80 mg

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and Female subjects in good general health, aged 18 to 65 years.
  • Subjects should meet IHS diagnostic criteria for migraine with or without aura.
  • Based on past history, subjects should expect to suffer at least one acute attack of migraine with or without aura, each 6 weeks

You may not qualify if:

  • Known coronary-artery disease, clinically significant arrhythmia, heart failure, or uncontrolled hypertension.
  • Pregnant or lactating women.
  • Clinically significant electrocardiogram abnormalities at screening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (148)

Eeuwfeestkliniek

Antwerp, 2018, Belgium

Location

A.Z. Sint Jan

Bruges, 8000, Belgium

Location

Cliniques Universitaires St Luc

Brussels, 1200, Belgium

Location

C.H.U. de Charleroi

Charleroi, 6000, Belgium

Location

Hopital de La Citadelle

Liège, 4000, Belgium

Location

Faculty Hospital U Svety Anny

Brno, 65691, Czechia

Location

Neurologika Klinika F.N.

Hradec Králové, 50005, Czechia

Location

Pain Centrum

Prague, 12 850, Czechia

Location

1St Medical Faculty of the Charles University

Prague, 12000, Czechia

Location

Arhus Kommunehospital

Arhus C, 8000, Denmark

Location

Kas Glostrup

Glostrup Municipality, 2600, Denmark

Location

Korsgaard, Anne G. (Private Practice)

Odense C, 5000, Denmark

Location

Asbjorn Ziebel

Roskilde, 4000, Denmark

Location

Peter Staehr

Ølstykke, 3650, Denmark

Location

Hopital de Rangueil

Toulouse, Cedex 04, 31403, France

Location

Veyrie-Courtade

Toulouse, Tououse, 31500, France

Location

C.H.U.R Bretonneau

Tours, Tours, 37044, France

Location

Kubler Altkirch

Altkirch, 68130, France

Location

Marcombes Angouleme

Angoulême, 16000, France

Location

Houdart Anzin

Anzin, 59416, France

Location

Groupe Pellegrin Tripode

Bordeaux, 33076, France

Location

Siboni Carcassonne

Carcassonne, 11000, France

Location

Hopital Louis Mourier

Colombes, 92701, France

Location

Cormier Laval

Laval, 53000, France

Location

Hopital Salengro

Lille, 59037, France

Location

Hopital Louis Pradel

Lyon, 69394, France

Location

Hopital Pasteur

Nice, 06200, France

Location

Private Practice

Orléans, 45000, France

Location

Delfiner Paris

Paris, 75015, France

Location

Hopital Lariboisiere

Paris, 75475, France

Location

Hopital Cochin

Paris Codex 14, 75679, France

Location

Vaunaize Reims (Ds For Oc)

Reims, 51100, France

Location

Vaunaize Reims

Reims, 51100, France

Location

Hopital Charles Nicolle

Rouen, 76031, France

Location

Hospital Bellevue

Saint-Etienne, 42055, France

Location

Bouchacourt Toulon

Toulon, 83 000, France

Location

Lemarquis Toulon

Toulon, 83000, France

Location

Mick Voiron

Voiron, 38500, France

Location

Private Practice

Berlin, 10117, Germany

Location

Private Practice

Berlin, 12687, Germany

Location

Private Practice (Guenther Schumann)

Bochum, 44805, Germany

Location

Private Practice

Bochum, 44807, Germany

Location

Private Practice

Eckernförde, 24340, Germany

Location

Private Practice

Göttingen, 37073, Germany

Location

Private Practice

Hamburg, 22149, Germany

Location

Private Practice

Oldenburg, 26131, Germany

Location

Fachklinik Fuer Neurologie Dietenbronn Gmbh

Schwendi, 88475, Germany

Location

Private Practice (Dr. Renate Kreyer)

Stade, 21680, Germany

Location

Neurology Clinic of Chania

Soúda, Chania,crete, 73100, Greece

Location

General Athens State Hospital

Athens, GR 156 69, Greece

Location

Saint Dimitrios Hospital

Thessaloniki, GR 546 34, Greece

Location

Peterfy Teaching Hospital

Budapest, 1076, Hungary

Location

Semmelweis University

Budapest, 1083, Hungary

Location

Szent-Imre Hospital

Budapest, 1115, Hungary

Location

Jahn Ferenc Hospital

Budapest, 1201, Hungary

Location

Uzsoki Hospital

Budapest, 1426, Hungary

Location

University of Debrecen, Medical and Health Science Centre, Medical School

Debrecen, 4012, Hungary

Location

Kenezy County Hospital

Debrecen, 4034, Hungary

Location

Universita Degli Studi Di Modena-Policlinico Dipartimento Di Medicina Interna

Modena, Emilia-Romagna, 41100, Italy

Location

Fondazione Istituto Neurologico Casimiro Mondino Istituto Di Ricovero E Cura A Carattere Scientifico

Pavia, Lombardy, 27100, Italy

Location

Universita' Di Bologna

Bologna, 40123, Italy

Location

Poliambulatorio Salus

Brescia, 25100, Italy

Location

Universita' Degli Studi Di Cagliari - Presidio Osp.S.Giovanni Di Dio

Cagliari, 09124, Italy

Location

Azienda Vittorio Emanuele

Catania, 95100, Italy

Location

Clinica Neurologica

L'aquila-coppito, 67100, Italy

Location

Policlinico Universitario

Messina, 98125, Italy

Location

Centro Cefalee Irccs "C. Besta"

Milan, 20133, Italy

Location

Universita Di Padova

Padua, 35128, Italy

Location

Centro Cefalee

Parma, 43100, Italy

Location

Clinica Neurologica, Universita Di Perugia

Perugia, 06126, Italy

Location

Centro Cefalee - Neuromed

Pozzilli (isernia), 86077, Italy

Location

Ospedale S. Eugenio

Roma, 00100, Italy

Location

Centro Cefalee

Torino, 10126, Italy

Location

Ospedale Regionale Torrette

Torrette DI Ancona (AN), 60020, Italy

Location

Ospedale Maggiore

Trieste, 34126, Italy

Location

Ospedale S. Bortolo

Vicenza, 36100, Italy

Location

Bosch Medicentrum (Locatie Willem Alexander Ziekenhuis)

's-Hertogenbosch, 5223GV, Netherlands

Location

Sint Lucas Andreas Ziekenhuis (Location: St.Lucas)

Amsterdam, 1061 AE, Netherlands

Location

Gelre Ziekenhuis (Location: Lukas)

Apeldoorn, 7334 DZ, Netherlands

Location

Ziekenhuis Gooi-Noord

Blaricum, 1261 AN, Netherlands

Location

Ignatius Ziekenhuis Breda

Breda, 4818 CK, Netherlands

Location

Gelderse Vallei Ziekenhuis

Ede, 6711 PV, Netherlands

Location

Scheperziekenhuis

Emmen, 7824 AA, Netherlands

Location

Atrium Heerlen

Heerlen, 6419 PC, Netherlands

Location

St. Streekziekenhuis Midden Twente

Hengelo (OV), 7555DL, Netherlands

Location

Ikazia Ziekenhuis

Rotterdam, 3083 AN, Netherlands

Location

Sint Elisabeth Ziekenhuis

Venray, 5801 CE, Netherlands

Location

Lage Land Ziekenhuis

Zoetermeer, 2725 NA, Netherlands

Location

Sentralsykehuset I Akershus

Nordbyhagen, 1474, Norway

Location

Volvat Medisinske Senter

Oslo, 0303, Norway

Location

Strandquist, Dr. Stein Bror

Tønsberg, 3111, Norway

Location

Hospital Garcia Da Orta

Almada, 2800, Portugal

Location

Centro Hospitalar de Coimbra

Coimbra, 3000, Portugal

Location

Hospital S.Joao

Porto, 4000, Portugal

Location

Consorci Hospitalari Del Parc Tauli

Sabadell, Barcelona, 08208, Spain

Location

Hospital Universitario de Puerto Real

Puerto Real, Cadiz, 11510, Spain

Location

Fundacion Hospital Alcorcon

Alcorcón, Madrid, 28922, Spain

Location

Hospital de Galdakao

Galdakao, Vizcaya, 48960, Spain

Location

Hospital Torrecardenas

Almería, 04009, Spain

Location

Hospital Del Sagrado Corazon

Barcelona, 08029, Spain

Location

Hospital General Universitari Vall D�Hebron

Barcelona, 08035, Spain

Location

Hospital General Yag�

Burgos, 09005, Spain

Location

Hospital Nuestra SE�Ra de Alarcos

Ciudad Real, 13002, Spain

Location

Hospital Na Sa de Aranzazu

Donostia / San Sebastian, 20014, Spain

Location

Hospital Ciudad de Jaen

Jaén, 23007, Spain

Location

Hospital Universitari de Lleida Arnau de Vilanova

Lleida, 25198, Spain

Location

Hospital Ramon Y Cajal

Madrid, 28034, Spain

Location

Hospital Universitario San Carlos

Madrid, 28040, Spain

Location

Hospital Virgen de La Victoria

Málaga, 29010, Spain

Location

Hospital General Universitario J. M. Morales Meseguer

Murcia, 30008, Spain

Location

Hospital General de Asturias

Oviedo, 33006, Spain

Location

Hospital Nuestra SE�Ra de Valme

Seville, 41014, Spain

Location

Hospital Clinico Universitario La Fe

Valencia, 46009, Spain

Location

Hospital General Universitario

Valencia, 46014, Spain

Location

Fritsla Vardcentral

Fritsla, 510 29, Sweden

Location

Migranklinik-Goeteborg

Gothenburg, SE-411 17, Sweden

Location

Lanssjukhuset Halmstad

Halmstad, 301 85, Sweden

Location

Viktoriakliniken

Halmstad, 30246, Sweden

Location

Neurologsektionen, Lasarettet

Helsingborg, 251 87, Sweden

Location

Neuro Kliniken, Helsingborg

Helsingborg, 25221, Sweden

Location

Sjocrona Vardcentral

Höganäs, 263 26, Sweden

Location

Huddinge Universitetssjukhus

Huddinge, Sweden

Location

Kistahalsan Ab

Kista, 164 40, Sweden

Location

Lund Lakarmottagningen

Lund, 221 21, Sweden

Location

Medicin Kliniken, Universitetssjukhuset

Lund, 22185, Sweden

Location

Lakargruppen Gustaf Adolf

Malmo, 211 36, Sweden

Location

Previa Ab Sigtunahalsan

Märsta, 195 30, Sweden

Location

Oxelohalsan

Oxelösund, 613 30, Sweden

Location

Bankhalsan

Stockholm, 105 34, Sweden

Location

Lakarhuset Odenplan

Stockholm, 113 22, Sweden

Location

Ostermalmshalsan

Stockholm, 11486, Sweden

Location

St Gorans Sjukhus

Stockholm, SE-112 81, Sweden

Location

Tyresohalsan Huslakare Ab (Ds For Oc)

Tyreso, 135 21, Sweden

Location

Tyresohalsan Huslakare Ab

Tyreso, 135 21, Sweden

Location

Kronobergskliniken

Vaxjo, SE-352 34, Sweden

Location

Centrallasarettet

Västerås, 721 89, Sweden

Location

Vasterviks Sjukhus

Västervik, 593 81, Sweden

Location

Novakliniken

Ystad, 271 39, Sweden

Location

Cukurova University Medical Faculty

Adana, 01330, Turkey (Türkiye)

Location

Karadeniz Technical University Medical Faculty

Trabzon, 61080, Turkey (Türkiye)

Location

Ahepa University Hospital

Location

Foretagshalsovarden Linden

Location

Huslakargruppen

Location

Limhamns Lakargrupp, Tarnan

Location

Medicinskt Centrum

Location

Sentralsjukehuset I Hedmark

Location

Sint Anna Ziekenhuis

Location

Vardcentralen

Location

Related Publications (1)

  • Almas M, Tepper SJ, Landy S, Schweizer E, Ramos E. Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study. Cephalalgia. 2014 Feb;34(2):126-35. doi: 10.1177/0333102413500726. Epub 2013 Aug 14.

Related Links

MeSH Terms

Conditions

Migraine without AuraMigraine with Aura

Interventions

eletriptan

Condition Hierarchy (Ancestors)

Migraine DisordersHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2013

First Posted

May 22, 2013

Study Start

March 1, 2000

Primary Completion

March 1, 2002

Study Completion

March 1, 2002

Last Updated

January 27, 2021

Record last verified: 2021-01

Locations